Cargando…

Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms

One decade after the genomic and the proteomic life science revolution, new ‘omics’ fields are emerging. The metabolome encompasses the entity of small molecules—Most often end products of a catalytic process regulated by genes and proteins—with the lipidome being its fat soluble subdivision. Within...

Descripción completa

Detalles Bibliográficos
Autores principales: Köfeler, Harald C., Fauland, Alexander, Rechberger, Gerald N., Trötzmüller, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901195/
https://www.ncbi.nlm.nih.gov/pubmed/24957366
http://dx.doi.org/10.3390/metabo2010019
_version_ 1782300814955511808
author Köfeler, Harald C.
Fauland, Alexander
Rechberger, Gerald N.
Trötzmüller, Martin
author_facet Köfeler, Harald C.
Fauland, Alexander
Rechberger, Gerald N.
Trötzmüller, Martin
author_sort Köfeler, Harald C.
collection PubMed
description One decade after the genomic and the proteomic life science revolution, new ‘omics’ fields are emerging. The metabolome encompasses the entity of small molecules—Most often end products of a catalytic process regulated by genes and proteins—with the lipidome being its fat soluble subdivision. Within recent years, lipids are more and more regarded not only as energy storage compounds but also as interactive players in various cellular regulation cycles and thus attain rising interest in the bio-medical community. The field of lipidomics is, on one hand, fuelled by analytical technology advances, particularly mass spectrometry and chromatography, but on the other hand new biological questions also drive analytical technology developments. Compared to fairly standardized genomic or proteomic high-throughput protocols, the high degree of molecular heterogeneity adds a special analytical challenge to lipidomic analysis. In this review, we will take a closer look at various mass spectrometric platforms for lipidomic analysis. We will focus on the advantages and limitations of various experimental setups like ‘shotgun lipidomics’, liquid chromatography—Mass spectrometry (LC-MS) and matrix assisted laser desorption ionization-time of flight (MALDI-TOF) based approaches. We will also examine available software packages for data analysis, which nowadays is in fact the rate limiting step for most ‘omics’ workflows.
format Online
Article
Text
id pubmed-3901195
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-39011952014-05-27 Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms Köfeler, Harald C. Fauland, Alexander Rechberger, Gerald N. Trötzmüller, Martin Metabolites Review One decade after the genomic and the proteomic life science revolution, new ‘omics’ fields are emerging. The metabolome encompasses the entity of small molecules—Most often end products of a catalytic process regulated by genes and proteins—with the lipidome being its fat soluble subdivision. Within recent years, lipids are more and more regarded not only as energy storage compounds but also as interactive players in various cellular regulation cycles and thus attain rising interest in the bio-medical community. The field of lipidomics is, on one hand, fuelled by analytical technology advances, particularly mass spectrometry and chromatography, but on the other hand new biological questions also drive analytical technology developments. Compared to fairly standardized genomic or proteomic high-throughput protocols, the high degree of molecular heterogeneity adds a special analytical challenge to lipidomic analysis. In this review, we will take a closer look at various mass spectrometric platforms for lipidomic analysis. We will focus on the advantages and limitations of various experimental setups like ‘shotgun lipidomics’, liquid chromatography—Mass spectrometry (LC-MS) and matrix assisted laser desorption ionization-time of flight (MALDI-TOF) based approaches. We will also examine available software packages for data analysis, which nowadays is in fact the rate limiting step for most ‘omics’ workflows. MDPI 2012-01-05 /pmc/articles/PMC3901195/ /pubmed/24957366 http://dx.doi.org/10.3390/metabo2010019 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Köfeler, Harald C.
Fauland, Alexander
Rechberger, Gerald N.
Trötzmüller, Martin
Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title_full Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title_fullStr Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title_full_unstemmed Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title_short Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
title_sort mass spectrometry based lipidomics: an overview of technological platforms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901195/
https://www.ncbi.nlm.nih.gov/pubmed/24957366
http://dx.doi.org/10.3390/metabo2010019
work_keys_str_mv AT kofelerharaldc massspectrometrybasedlipidomicsanoverviewoftechnologicalplatforms
AT faulandalexander massspectrometrybasedlipidomicsanoverviewoftechnologicalplatforms
AT rechbergergeraldn massspectrometrybasedlipidomicsanoverviewoftechnologicalplatforms
AT trotzmullermartin massspectrometrybasedlipidomicsanoverviewoftechnologicalplatforms